ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Philadelphia, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Lung Cancer trials near Philadelphia, PA, USA:

A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer

in patients undergoing surgical thoracoscopy and resection of lung cancer. Safety is the primary objective of this study, followed ...

Enrolling
Lung Cancers
Drug: LS301-IT

Phase 1

Integro Theranostics

Philadelphia, Pennsylvania, United States

Investigators are conducting a pragmatic randomized trial testing the effectiveness of patient and clinician nudge strategies on adherence to lung...

Enrolling
Lung Cancer
Adherence, Patient
Behavioral: Patient Nudge
Behavioral: Clinician Nudge
Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine

Philadelphia, Pennsylvania, United States

a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

Camden, New Jersey, United States and 59 other locations

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

Philadelphia, Pennsylvania, United States and 30 other locations

in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participants with extensive stage-small cell lung...

Enrolling
Extensive Stage-small Cell Lung Cancer
Drug: Carboplatin
Drug: Ifinatamab deruxtecan

Phase 1, Phase 2

Daiichi Sankyo
Daiichi Sankyo

Philadelphia, Pennsylvania, United States and 49 other locations

The primary objective of this study is to compare the efficacy of tarlatamab with placebo as assessed by progression free survival (PFS).

Enrolling
Small Cell Lung Cancer
Limited Stage Small Cell Lung Cancer
Drug: Placebo
Drug: Tarlatamab

Phase 3

Amgen
Amgen

Allentown, Pennsylvania, United States and 188 other locations

This is a phase I dose escalation study of CAN-2409 plus prodrug in patients with non-small cell lung cancer (NSCLC). The primary c...

Active, not recruiting
Lung Cancer
Biological: CAN-2409 + valacyclovir

Phase 1

Candel Therapeutics

Philadelphia, Pennsylvania, United States

The main aim of this study is to:* evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST 1.1\]...

Active, not recruiting
Relapsed/Refractory Small Cell Lung Cancer
Drug: Tarlatamab

Phase 2

Amgen
Amgen

Newark, Delaware, United States and 79 other locations

therapy in treating patients with stage II-IIIB non-small cell lung cancer. Monoclonal antibodies, such as pembrolizumab, may inter...

Active, not recruiting
Stage IIIA Non-Small Cell Lung Cancer
Stage IIIB Non-Small Cell Lung Cancer
Drug: Carboplatin
Radiation: Intensity-Modulated Radiation Therapy

Phase 1

Rutgers The State University of New Jersey
Rutgers The State University of New Jersey

Philadelphia, Pennsylvania, United States and 2 other locations

This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...

Active, not recruiting
Small Cell Lung Cancer
Drug: Durvalumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Philadelphia, Pennsylvania, United States and 182 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems